Back

GLP1 receptor agonists and CAD regression in diabetic patients after ACS

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Diabetes and coronary artery disease Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Mauro Gitto

Humanitas University, Milan (Italy)

6 More presentations in this session

Presentation thumbnail
Differential effects of glucose-lowering agents on atherosclerotic plaque progression in diabetic patients: a retrospective cohort study using serial coronary CT angiography
Doctor J. Zhang (Chengdu, CN)
Abstract Slides Video
Presentation thumbnail
Participant-level pericoronary adipose tissue attenuation predicts changes in plaque composition: a 1-year prospective study in asymptomatic individuals with type 2 diabetes mellitus
Doctor K. Overgaard (Svendborg, DK)
Abstract Slides Video
Presentation thumbnail
Glycemic control and renal function decline in patients with chronic coronary syndrome
Doctor C. HUANG (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Impact of prediabetes on long-term outcomes after percutaneous coronary interventions
Doctor E. Steinacher (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Diabetes status and grade of left ventricular ejection fraction as predictors of outcomes in patients with Non-ST-segment elevation myocardial infarction
Professor Y. Kim (Chuncheon, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Diabetes and coronary artery disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Differential effects of glucose-lowering agents on atherosclerotic plaque progression in diabetic patients: a retrospective cohort study using serial coronary CT angiography
thumbnail
Congress Presentation
Diabetes and prediabetes prevalence and guideline directed antidiabetic therapy in acute coronary syndrome and complex coronary interventions
thumbnail
Congress Presentation
Effects on re-endothelialisation with Bydureon treatment add on to insulin versus insulin alone, both in combination with metformin in type 2 diabetic subjects: Rebuild study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources